维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Robinson HM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Efficacy and safety of alirocumab as add- on therapy in high-cardiovascular- risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 rag): design and rationale of the ODYSSEY OPTIONS Studies显示文摘	ROBINSON JG COLHOUN HM BAYS HE	2014	Clin Cardiol2014，37，10：	1
2	Optimizing RNA extraction yield from whole blood for mieroarray gene expression analysis显示文摘	Wang J Robinson JF Khan HM	2004	Clin Biochem2004，37，9：	1
3	DNA mismatch repair and Chkl -dependent centrosome amplification in response to DNA alkylation damage 显示文摘	Robinson HM Black EJ Brown R	2007	Cell Cycle2007，6，8：	1
4	Duty - related srtessors and PTSD symptoma in suburban police officers显示文摘	Robinson HM Sigman MR	1997	Psychol Rep1997，81，3：	1
5	Growth hormone-defi cient dwarfism in the rat: a new mutation 显示文摘	Charlton HM Clark RG Robinson I	1988	J Endocrinol1988，119，1：	1
6	Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvas- tatin (20 or 40 nag) or rosuvastatin (10 or 20 mg): design and ratio- nale of the ODYSSEY OPTIONS Studies 显示文摘	Robinson JG Colhoun HM Bays HE	2014	Clin Cardiol2014，37，10：	1
7	Massive spontaneous hemothorax during the Immediate postpartum period 显示文摘	Doshi HM Robinson S Chalhoub T	2009	Tex Heart Inst J2009，36，3：	1
8	Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high car- diovascular risk patients with poorly controlled hypercholesterol- emia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO Ⅰ and Ⅱ trials 显示文摘	Colhoun HM Robinson JG Farnier M	2014	B2vlC Cardiovasc Disord2014，14，：	1
9	Complex genomie alterations and gene expression in acute lymphoblastic leukemia with intraehromosomal amplification of chromosome 21 显示文摘	Strefford JC Delft FW Robinson HM	2006	Proe Nail Aead Sei U S A2006，103，21：	1
10	Efficacy ami safety of a1irocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin(20 or 40 mg) or rosuvastatin( 10 or 20 mg) : design and rationale of the ODYSSEY OPtionS studies显示文摘	Robinson JG Colhoun HM Bays HE et a1	2014	Clin Cardiol2014，37，10：	1
11	Efficacy and safety of a1irocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins , rationale and design of the ODYSSEY COMBO I and II trials 显示文摘	Colhoun HM Robinson JG Farnier M et a1	2014	BMC Cardiovasc Disord2014，14，：	1
12	SIS/PDGF-B promoter isolation and characterization of regulatory elements necessary for basal expression of the SIS/PDGF-B gene in U2-osteosarcoma cells显示文摘	Robinson DF Liang Y	1994	J Biol Chem1994，269，28：	1
13	Duty-related stressors and PTSD symptoms in suburban police officers 显示文摘	Robinson HM Sigman MR	1997	Psychol Rep1997，81，3：	1
14	Torsion of the pregnant uterus显示文摘	Robinson AL Duvall HM	1931	J Obstet Gynaec Br Commonw1931，38，：	1
15	Duty-related stressors and PTSD symptom in suburban police officers显示文摘	Robinson HM Sigman MR	1997	Psychol Rep1997，81，3：	1
16	Progressive facial hemiatrophy:MRI appearances显示文摘	Taylor HM Robinson R Cox T	1997	Dev Med Child Neurol1997，39，7：	1
17	Efficacy and safety of alirocumab as add-on therapy in high-cardiovascu- lar-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin ( 10 or 20 mg) : design and rationale of the ODYSSEY OP- TIONS Studies 显示文摘	Robinson JG Colhoun HM Bays HE	2014	Clinical cardiology2014，37，10：	1
18	Cefotetan induced life-threatening haemolysis显示文摘	Robinson HE Maxwell EL Prince HM	2006	Med J Aust2006，184，5：	1
19	Quantitation of the distribution and flux of myosin-II during cytokinesis 显示文摘	Robinson DN Cavet G Warrick HM	2002	BMC Cell Biol2002，3，4：	1
20	SIS/PDGF-B promoter isolation and characterization of regulatory elements necessary for basal expression of the SIS/PDGF-B gene in U2-OS osteosarcoma cells显示文摘	Jin HM Robinson DF Liang Y	1994	J Biol Chem1994，269，28：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示